Eagle Pharmaceuticals,Inc. (NASDAQ:EGRX) Files An 8-K Other EventsItem 8.01 Other Events.
On November27, 2018, Eagle Pharmaceuticals,Inc. issued a press release announcing positive results of a pre-clinical study conducted to evaluate the effects of RYANODEX®(dantrolene sodium) in Acute Radiation Syndrome.
A copy of the full text of the press release referenced above is filed as Exhibit99.1 to this Current Report on Form8-K and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
ExhibitNo. |
Description |
99.1 |
Press Release dated November27, 2018 |